Barwon Health Research Operations ManagerBarwon HealthGeelong, Victoria, Australia
Disclosure information not submitted.
547 - An Open-label Multicenter Phase 2 Trial of Telacebec for Adults with Buruli ulcer: the TREAT-BU Trial
Wednesday, October 22, 202510:42 AM - 10:54 AM US ET